Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
A New Approach to Cancer Second Opinions: Overcoming the Challenges of Conventional Oncology Practice by Providing Education to Patients and Physicians.
Journal: Journal of cancer education : the official journal of the American Association for Cancer Education
Published: March 08, 2025
Early Detection and Prognostic Assessment of Cutaneous Melanoma: Consensus on Optimal Practice and the Role of Gene Expression Profile Testing.
Journal: JAMA dermatology
Published: March 15, 2023
Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 07, 2023
Prognostic Gene Expression Profiling in Cutaneous Melanoma: Identifying the Knowledge Gaps and Assessing the Clinical Benefit.
Journal: JAMA dermatology
Published: July 30, 2020
Five-Year Survival and Correlates Among Patients With Advanced Melanoma, Renal Cell Carcinoma, or Non-Small Cell Lung Cancer Treated With Nivolumab.
Journal: JAMA oncology
Published: July 26, 2019
Five-Year Follow-Up of Nivolumab in Previously Treated Advanced Non-Small-Cell Lung Cancer: Results From the CA209-003 Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 24, 2018
Skin cancer screening: recommendations for data-driven screening guidelines and a review of the US Preventive Services Task Force controversy.
Journal: Melanoma management
Published: June 10, 2016
Overall Survival and Long-Term Safety of Nivolumab (Anti-Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 22, 2015
Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 05, 2014
A randomized phase II trial of multiepitope vaccination with melanoma peptides for cytotoxic T cells and helper T cells for patients with metastatic melanoma (E1602).
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 09, 2013
Phase III trial of carboplatin and paclitaxel with or without sorafenib in metastatic melanoma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 19, 2012
Last Updated: 09/26/2026